Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function

被引:337
作者
Jiang, F
Ryan, MT
Schlame, M
Zhao, M
Gu, ZM
Klingenberg, M
Pfanner, N
Greenberg, ML [1 ]
机构
[1] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA
[2] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany
[3] Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA
[4] Univ Munich, inst Phys Biochem, D-80336 Munich, Germany
关键词
D O I
10.1074/jbc.M909868199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiolipin (CL) is a unique phospholipid which is present throughout the eukaryotic kingdom and is localized in mitochondrial membranes. Saccharomyces cerevisiae cells containing a disruption of CRD1, the structural gene encoding CL synthase, have no CL in mitochondrial membranes. To elucidate the physiological role of CL, we compared mitochondrial functions in the crd1 Delta mutant and isogenic wild type. The crd1 Delta mutant loses viability at elevated temperature, and prolonged culture at 37 degrees C leads to loss of the mitochondrial genome. Mutant membranes have increased phosphatidylglycerol (PG) when grown in a nonfermentable carbon source but have almost no detectable PG; in medium containing glucose. In glucose-grown cells, maximum respiratory rate, ATPase and cytochrome oxidase activities, and protein import are deficient in the mutant. The ADP/ATP carrier is defective even during growth in a nonfermentable carbon source. The mitochondrial membrane potential is decreased in mutant cells. The decrease is more pronounced in glucose-grown cells, which lack PG;, but is also apparent in membranes containing PC: (i.e. in nonfermentable carbon sources). We propose that CL is required for maintaining the mitochondrial membrane potential and that reduced membrane potential in the absence of CL leads to defects in protein import and other mitochondrial functions.
引用
收藏
页码:22387 / 22394
页数:8
相关论文
共 56 条
[41]   Functional staging of ADP ATP carrier translocation across the outer mitochondrial membrane [J].
Ryan, MT ;
Müller, H ;
Pfanner, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) :20619-20627
[42]  
Sambrook F E. F., 1989, MOL CLONING LAB MANU
[43]   Cardiolipin synthase from yeast [J].
Schlame, M ;
Greenberg, ML .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1997, 1348 (1-2) :201-206
[44]   MITOCHONDRIAL CARDIOLIPIN IN DIVERSE EUKARYOTES - COMPARISON OF BIOSYNTHETIC REACTIONS AND MOLECULAR ACYL SPECIES [J].
SCHLAME, M ;
BRODY, S ;
HOSTETLER, KY .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 212 (03) :727-735
[45]  
Schlame M, 1999, J LIPID RES, V40, P1585
[46]   STUDIES ON MECHANISM BY WHICH CYANINE DYES MEASURE MEMBRANE-POTENTIAL IN RED BLOOD-CELLS AND PHOSPHATIDYLCHOLINE VESICLES [J].
SIMS, PJ ;
WAGGONER, AS ;
WANG, CH ;
HOFFMAN, JF .
BIOCHEMISTRY, 1974, 13 (16) :3315-3330
[47]  
SOLLNER T, 1991, METHOD CELL BIOL, V34, P345
[48]   IN-VITRO STUDIES OF PHOSPHOLIPID BIOSYNTHESIS IN SACCHAROMYCES-CEREVISIAE [J].
STEINER, MR ;
LESTER, RL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) :222-&
[49]   NUCLEAR MUTANT OF S CEREVISIAE NON-TOLERATING CYTOPLASMIC PETITE MUTATION [J].
SUBIK, J .
FEBS LETTERS, 1974, 42 (03) :309-313
[50]   BIOCHEMICAL-CHARACTERIZATION AND REGULATION OF CARDIOLIPIN SYNTHASE IN SACCHAROMYCES-CEREVISIAE [J].
TAMAI, KT ;
GREENBERG, ML .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1046 (02) :214-222